Bharat biotech, Biotechnology company

Hyderabad, June 16 Bharat Biotech dispatched its Covid-19 vaccine Covaxin to nine states through the government of India and to 16 states through the respective state governments.Company's co-founder and joint managing director Suchitra Ella on Wednesday tweeted that Andhra Pradesh, Assam, Delhi, Gujarat, Karnataka, Madhya Pradesh, Maharashtra, Tamil Nadu and Telangana were supplied the vaccines through government of India from June 8 to 14.The Hyderabad-based vaccine maker also made supplies to 16 states during the same period. The states are Assam, Bihar, Chhattisgarh, Delhi, Haryana, Jharkhand, Karnataka, Madhya Pradesh, Odisha, Punjab, Rajasthan, Tamil Nadu, Telangana, Tripura, Uttarakhand and West Bengal.She also tweeted that vaccine doses were also dispatched to private hospitals in 27 cities across the country from June 8 to 14.These include Delhi, Mumbai, Chennai, Kolkata, Bangalore and Hyderabad. A total of seven cities in Telangana and Andhra were dispatched the vaccine under this category.She, however, has not provided details like the number of doses dispatched under the three categories."Our mission is to deliver Covaxin to your towns-cities & states. Pls register & vaccinate @ govt or pvt hospitals near you," tweeted Suchitra Ella.The company had Monday defended differential pricing policy for the central and state governments and private sector.It said that the supply price of Covaxin to the government of India at Rs 150 per dose, is a non-competitive price and clearly not sustainable in the long run. Hence a higher price in private markets is required to offset part of the costs, it said in a statement.The company clarified that Covaxin is more expensive for private sector is due to fundamental business reasons, ranging from low procurement volumes, high distribution costs and retail margins.At Rs 1,200 per dose for private hospitals, Covaxin is reported to be third costly vaccine globally.Bharat Biotech had fixed the price of Covaxin for state governments at Rs 600 per dose but later slashed it to Rs 400.Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Bharat BiotechFOLLOW

Bharat biotech, Latest News

The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin to Drugs Controller General of India (DCGI) over the weekend, according to government sources. ...

Hyderabad-based Bharat Biotech's Covaxin is expected to get World Health Organization (WHO) approval soon. Regarding this, Bharat Biotech has ... ...

Hyderabad-based Bharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use Listing (EUL) of its indigenous COVID-19 vaccine Covaxin. ...

India will bounce back after the major devastation it suffered during the second wave of the Covid-pandemic and the crisis cannot deter the "rise of the great country as a global super power," Shin Bong-Kil, the South Korean envoy to India said on We ...

There have been some social media posts regarding composition of the COVAXIN vaccine where it has been suggested that ... ...

The Union Health Ministry on Wednesday said that newborn calf serum is not an ingredient of the final Covaxin vaccine by Bharat Biotech. ...

Hyderabad, June 16 Bharat Biotech on Wednesday clarified that while new born calf serum is used in the ... ...

Hyderabad, June 16 Bharat Biotech dispatched its Covid-19 vaccine Covaxin to nine states through the government of India ... ...